Guyana vs Slovakia: Access to anti-retroviral drugs, male
Guyana
66.0%
in 2024
Slovakia
66.0%
in 2018
Guyana rank
80th
Slovakia rank
80th
Access to anti-retroviral drugs, male over time
- Guyana
- Slovakia
How they compare
Guyana currently reports 66.0% against 66.0% in Slovakia, a difference of 0.0%.
The two have swapped places 2 times across 19 shared years of data; in 2000 it was Slovakia ahead.
Guyana ranks 80th and Slovakia ranks 80th of 141 countries.
Slovakia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guyana | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.4% | 20.3% | 3.9% | Slovakia |
| 2010s | 48.1% | 49.0% | 0.9% | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Guyana or Slovakia?
- Guyana, at 66.0% against 66.0% in Slovakia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Guyana and Slovakia?
- 0.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Slovakia?
- 19 years are reported by both, from 2000 to 2018.
- How do Guyana and Slovakia rank globally for access to anti-retroviral drugs, male?
- Guyana ranks 80th and Slovakia ranks 80th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.